Covid-19 roundup: Re­gen­eron asks FDA: Which gov­ern­ment agen­cies are track­ing vari­ants of con­cern?; Pfiz­er, As­traZeneca vac­cines most­ly hold strong against Delta vari­ant

As the race to keep Covid-19 vari­ants at bay con­tin­ues, Re­gen­eron is call­ing on the FDA to pro­vide ad­di­tion­al clar­i­ty on which gov­ern­ment agen­cies are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.